Is MAC a Good Stock to Buy? The Bull and Bear Case (2026)
Last updated November 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for The Macerich Company (MAC) rests on Deleveraging toward the 6x goal: Reducing leverage is the stated centerpiece of the Path Forward Plan, and progress has been measurable: net debt to adjusted EBITDA fell to about 7.3x in the second quarter of 2026, down more than 1.5 turns since the plan began, and lands near 6.8x pro forma for the forward equity proceeds. The bear case rests on dilution is the most concrete cost of the turnaround: two 2026 equity offerings plus a $675 million exchangeable note materially raised the share and unit count, which is why FFO per share has barely moved even as total FFO grew. Analysts covering it publish targets from $20.00 to $30.00 against a $24.88 share price on November 16, 2026, so even the professionals disagree by 37% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
MAC key stats
At $24.88 on November 16, 2026, The Macerich Company (MAC) has a market cap of $7.3B and a dividend yield of 2.73%.
- Market cap
- $7.3B
- Price to book
- 2.6
- Dividend yield
- 2.73%
- Beta
- 2.12
Market cap, P/E and yield are measured at the $24.88 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.
What's new with The Macerich Company (MAC)?
The last two weeks for The Macerich Company, as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.
- MAC closed at $24.88 on November 16, 2026, down 1.6% over the past five trading days (from $25.29).
- On November 16, 2026, The Macerich Company filed an 8-K with the SEC reporting information shared with investors (Regulation FD) and other events (Item 7.01, Item 8.01). Read the 8-K on sec.gov
- On November 5, 2026, The Macerich Company filed its quarterly report (10-Q) with the SEC. Read the 10-Q on sec.gov
- On November 4, 2026, The Macerich Company filed an 8-K with the SEC reporting quarterly results and information shared with investors (Regulation FD) (Item 2.02, Item 7.01). Read the 8-K on sec.gov
- On November 6, 2026, Evercore ISI Group raised its target to $27.00 from $25.00 (Outperform).
Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.
The Macerich Company, founded in 1964 and headquartered in Santa Monica, California, owns, leases and redevelops regional town centers in dense, higher-income US markets. Its holdings cluster in California, the Pacific Northwest, the Phoenix and Scottsdale corridor, and the stretch from metro New York to Washington, DC, with flagships including Tysons Corner Center, Queens Center, Scottsdale Fashion Square, Washington Square and Green Acres Mall. After several years of selling and handing back weaker assets, the portfolio sat at roughly 38 to 39 retail centers and about 40 million square feet as of the second quarter of 2026, down from 48 million square feet earlier in the program. Trailing 12-month tenant sales for spaces under 10,000 square feet reached about $919 per square foot, up from roughly $849 a year earlier, and trailing revenue runs near $1.03 billion. The investment picture is a leverage story wrapped around an operating recovery. Under CEO Jackson Hsieh, the Path Forward Plan has completed about $1.3 billion of dispositions, returned troubled centers to their lenders, bought out joint-venture partners on core assets, and pivoted to offense with the roughly $272 million Annapolis Mall purchase in May 2026. Funding that shift required real dilution: a 22.08 million share offering at $21.00, a 14 million share forward offering priced at $23.90, and a $675 million 2.25% exchangeable note due 2031. Net debt to adjusted EBITDA improved to about 7.3x in the second quarter, or roughly 6.8x pro forma for the forward equity, against a long-term target near 6x. Second-quarter FFO as adjusted came in at $0.35 per share on $249.7 million of revenue, while GAAP results stayed in the red at a $0.10 per share loss, which is normal for a depreciation-heavy landlord. At roughly $23.18 on October 16, 2026 and a market capitalization near $6.8 billion, the shares price in a good deal of the company's own $1.80 to $2.00 per share 2028 FFO ambition. The stock is up about 25% in 2026 and about 36% over twelve months, though it has slipped roughly 10% over the past three months from a 52-week high near $26.68. Sell-side sentiment turned warmer after the second quarter: Piper Sandler upgraded the shares to Overweight with a $30 target in late August, JPMorgan moved to Overweight with a $26 target in September, and BNP Paribas initiated at Outperform with a $28 target in October, leaving the average of 16 analyst targets near $26.62. Third-quarter results are scheduled for November 4, 2026, with consensus looking for revenue near $248 million.
The bull case: what would have to be true for $30.00
The most optimistic published target on MAC is $30.00, +20.6% from the $24.88 share price on November 16, 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Deleveraging toward the 6x goal
Reducing leverage is the stated centerpiece of the Path Forward Plan, and progress has been measurable: net debt to adjusted EBITDA fell to about 7.3x in the second quarter of 2026, down more than 1.5 turns since the plan began, and lands near 6.8x pro forma for the forward equity proceeds. Management frames the low-to-mid 6x range as reachable within a few years and holds 6x as the 2028 target. Total pro-rata debt across the portfolio stood at roughly $6.3 billion against about $1.2 billion of liquidity, so refinancing capacity has widened considerably from the plan's starting point.
2. The signed-not-open rent pipeline
Leases already signed but not yet paying rent are the most visible source of near-term FFO growth. The pipeline reached about $124 million of a $140 million target, with roughly $30 million of that revenue expected to land in 2026, $40 million to $45 million in 2027 and $45 million to $50 million in 2028. Because the rent is contracted rather than forecast, this pipeline is the reason go-forward NOI growth is expected to accelerate after 2026 rather than simply continue at the current pace.
3. Consolidating and upgrading the go-forward portfolio
Roughly 90% of go-forward NOI now comes from Class A assets, a mix achieved by shedding weaker centers and concentrating capital in the survivors. Annapolis Mall was acquired at a targeted stabilized yield in the 9% to 11% range, and in-process redevelopment at FlatIron Crossing, Green Acres Mall and Scottsdale Fashion Square carries estimated costs of about $459 million to $505 million. Another $300 million to $400 million of dispositions is expected by the end of 2026, which keeps the mix shifting toward the higher-productivity end.
4. Tenant productivity and leasing leverage
Occupancy and sales productivity both moved the right way in the second quarter: total portfolio leased occupancy hit 94% and go-forward occupancy reached 95.5%, up about 270 basis points year over year, on 1.3 million square feet of new and renewal leases signed. Tenant sales per square foot of roughly $919 give Macerich a stronger negotiating position on renewals than the mall sector's reputation implies. Of 2026 lease expirations, about 93% were committed to renew with another 6% at the letter-of-intent stage.
The bear case: what would have to be true for $20.00
The most pessimistic published target is $20.00, -19.6% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks The Macerich Company is worth if the risks below bite instead of the drivers above.
Dilution is the most concrete cost of the turnaround: two 2026 equity offerings plus a $675 million exchangeable note materially raised the share and unit count, which is why FFO per share has barely moved even as total FFO grew. Tenant credit remains a live drag, with Forever 21's liquidation alone releasing about 570,000 square feet across Macerich centers and Claire's filing again in 2025, so backfilling vacancy is a permanent operating expense rather than a one-time event. Property-level debt still bites: the $76 million loan secured by Twenty Ninth Street in Boulder sat in default after its February maturity, and while a single mortgage default is not a corporate solvency issue, it shows the asset-by-asset workout is unfinished. GAAP net losses persist and the dividend, at $0.17 per quarter or roughly $0.68 annualized, was cut deeply from pre-2020 levels and is covered by FFO rather than by earnings. Finally, the valuation itself is a risk: near 16 times trailing FFO and roughly 12 times the midpoint of the company's own 2028 target, the shares already assume the plan lands close to schedule, so a missed disposition, a rate move, or a weaker consumer would hit the multiple and the estimates at the same time.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding MAC already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on MAC
15 analysts cover MAC, with an average target of $26.73 (+7.4% against $24.88) and a split of 13 buy, 2 hold, 1 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the MAC forecast and price target page.
How is MAC valued?
Market cap, P/E and dividend yield at today's price are in the MAC key stats above. The business figures below come from The Macerich Company's reported results as of October 2026 and change when it next reports.
- Revenue (TTM): ~$1.03B, up ~1% year over year in the latest quarter (company-reported Q2 2026: ~$249.7M)
- FFO as adjusted per share: ~$0.35 in Q2 2026 and ~$0.70 for the first half, versus ~$1.50 for full-year 2025
- GAAP net income (TTM): ~$(170)M loss, about $(0.65) per share; Q2 2026 EPS of $(0.12) versus a $(0.06) consensus
- Margins (TTM): ~55% gross, ~16% operating, ~(16.5)% net, with EBITDA near $537M
- Net debt / adjusted EBITDA: ~7.3x at Q2 2026, or ~6.8x pro forma for forward equity, against a ~6x 2028 target
- Dividend: $0.68 annualized ($0.17 quarterly), ~2.95% yield; covered by FFO, not GAAP earnings
As of October 2026: At about $23 the shares trade near 16 times trailing FFO as adjusted and roughly 12 times the midpoint of management's $1.80 to $2.00 2028 target, so the price assumes the plan stays roughly on schedule. FFO per share has been close to flat while total FFO rose, because the 2026 equity raises expanded the denominator faster than the operating recovery grew the numerator. GAAP measures such as the trailing P/E are not meaningful for a depreciation-heavy REIT that reports net losses, which is why the forward P/E of about 169 on Yahoo looks extreme.
How do you decide if MAC is a buy?
Whether MAC is a buy is easier to judge through four narrower questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold MAC indirectly through an index or sector ETF before adding more.
What would change your mind on MAC
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Deleveraging toward the 6x goal stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
- Bear case breaks if: dilution is the most concrete cost of the turnaround: two 2026 equity offerings plus a $675 million exchangeable note materially raised the share and unit count, which is why FFO per share has barely moved even as total FFO grew fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the MAC stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about MAC against your real portfolio and see your actual exposure before deciding.
Your questions about The Macerich Company
Ask Walnut's AI anything about MAC and see how it fits what you own.
FAQ
Is MAC a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Deleveraging toward the 6x goal, with revenue (ttm) at ~$1.03B, up ~1% year over year in the latest quarter (company-reported Q2 2026: ~$249.7M). The bear case rests on dilution is the most concrete cost of the turnaround: two 2026 equity offerings plus a $675 million exchangeable note materially raised the share and unit count, which is why FFO per share has barely moved even as total FFO grew. Analysts covering it are spread from $20.00 to $30.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.
Should I sell MAC?
+
Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Dilution is the most concrete cost of the turnaround: two 2026 equity offerings plus a $675 million exchangeable note materially raised the share and unit count, which is why FFO per share has barely moved even as total FFO grew. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $20.00, -19.6% from the $24.88 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.
What is the bull case for MAC?
+
Deleveraging toward the 6x goal. Reducing leverage is the stated centerpiece of the Path Forward Plan, and progress has been measurable: net debt to adjusted EBITDA fell to about 7.3x in the second quarter of 2026, down more than 1.5 turns since the plan began, and lands near 6.8x pro forma for the forward equity proceeds. The most optimistic analyst target on MAC is $30.00, +20.6% from the $24.88 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for MAC?
+
Dilution is the most concrete cost of the turnaround: two 2026 equity offerings plus a $675 million exchangeable note materially raised the share and unit count, which is why FFO per share has barely moved even as total FFO grew. Tenant credit remains a live drag, with Forever 21's liquidation alone releasing about 570,000 square feet across Macerich centers and Claire's filing again in 2025, so backfilling vacancy is a permanent operating expense rather than a one-time event. Property-level debt still bites: the $76 million loan secured by Twenty Ninth Street in Boulder sat in default after its February maturity, and while a single mortgage default is not a corporate solvency issue, it shows the asset-by-asset workout is unfinished. GAAP net losses persist and the dividend, at $0.17 per quarter or roughly $0.68 annualized, was cut deeply from pre-2020 levels and is covered by FFO rather than by earnings. Finally, the valuation itself is a risk: near 16 times trailing FFO and roughly 12 times the midpoint of the company's own 2028 target, the shares already assume the plan lands close to schedule, so a missed disposition, a rate move, or a weaker consumer would hit the multiple and the estimates at the same time. The most pessimistic published target is $20.00, -19.6% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.
What does The Macerich Company do?
+
The Macerich Company is a REIT that owns, leases and redevelops Class A regional town centers in dense, higher-income US markets.
What would have to change for MAC to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Deleveraging toward the 6x goal) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (dilution is the most concrete cost of the turnaround: two 2026 equity offerings plus a $675 million exchangeable note materially raised the share and unit count, which is why FFO per share has barely moved even as total FFO grew) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
Who trades under the ticker MAC?
+
MAC is The Macerich Company, a retail real estate investment trust listed on the New York Stock Exchange. It should not be confused with MAC Cosmetics (a brand owned by Estee Lauder, not separately listed) or with Macquarie Infrastructure, which used the same ticker years ago. Macerich remains fully listed with no delisting determination, and it filed a Form 10-Q for the quarter ended June 30, 2026.
What is Macerich's dividend and is it covered?
+
The board declared a quarterly cash dividend of $0.17 per common share payable in late September 2026, which annualizes to roughly $0.68 and works out near a 2.9% to 3.0% yield at about $23.18 as of mid-October 2026. Measured against roughly $1.40 to $1.50 of annualized FFO as adjusted, coverage runs a little above 2x, which is conservative for a REIT and reflects the decision to direct cash toward deleveraging and redevelopment. The payout was cut sharply during the 2020 to 2021 period and has not been restored to its old level.
Why look at FFO instead of EPS for Macerich?
+
Real estate depreciation is a large non-cash charge that runs through a REIT's income statement even when buildings are holding or gaining value, which is why Macerich reports a GAAP net loss of about $0.10 per share in a quarter it also earned $0.35 per share of FFO as adjusted. Funds from operations adds depreciation and amortization back and strips out property sale gains, giving a closer read on recurring cash generation. Because REITs must distribute most of their taxable income, dividend coverage is also judged against FFO, not EPS.
Walnut is informational, not investment advice, and gives no verdict on MAC. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 16, 2026. Verify current figures with your broker before acting on them.